VC-backed arGEN-X raises €40m in IPO
Dutch VC-backed biotech arGEN-X has raised €40m from its IPO of new shares, giving it a market cap of €131.7m.
More on Benelux
Bugaboo backer Bain strolls back to market for H2 2022 launch
Sale of pram maker was initially launched last year but did not proceed due to credit market and consumer sector concerns
Adams Street secures USD 3.2bn for newest secondaries programme amid LP stakes dealflow uptick
Private markets investor has seen LP stakes increase as a proportion of its deployment over the past year, partner Jeff Akers said
Egeria to exit GoodLife Foods in SBO to IK Partners
Acquisition of Dutch frozen snack maker marks 13th investment from IK IX Fund
Golding aims to raise EUR 350m for next buyout co-investment fund amid ‘unprecedented’ dealflow
Vehicle expects to make its first deals this year, providing additional equity for deals against a tough fundraising backdrop
Latest News
Carlyle acquires Meopta
GP plans to support Czech-American optical products manufacturer’s international expansion
Bugaboo backer Bain strolls back to market for H2 2022 launch
Sale of pram maker was initially launched last year but did not proceed due to credit market and consumer sector concerns
Officine Maccaferri sees Cinven and Triton go head-to-head
Italy-based geotechnical and soil erosion control business could be valued at EUR 700m-EUR 800m
Adams Street secures USD 3.2bn for newest secondaries programme amid LP stakes dealflow uptick
Private markets investor has seen LP stakes increase as a proportion of its deployment over the past year, partner Jeff Akers said